𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardioprotective Effects of the Novel Selective Endothelin-A Receptor Antagonist BSF 461314 in Ischemia–Reperfusion Injury

✍ Scribed by HANSEN, A; BEKEREDJIAN, R; FILUSCH, A; WOLF, D; GROSS, M; MUELLER, S; KOROSOGLOU, G; KUECHERER, H

Book ID
123279406
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
483 KB
Volume
18
Category
Article
ISSN
1097-6795

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatoprotective effect of the endotheli
Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver
✍ Y Kitayama; N Yamanaka; E Kawamura; N Kuroda; E Okamoto 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 1 views

The present study was designed to investigate if TAKparallel with a decrease in hepatic arterial and portal blood 044, a novel endothelin (ET) ET A /ET B receptor antagoflow. These pathological changes were reversed after ET-1 nist, inhibits ischemia-reperfusion liver injury. The iniinfusion was com

Tezosentan, a novel endothelin receptor
Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models
✍ Douglas G. Farmer; Fady Kaldas; Dean Anselmo; Masamichi Katori; Xiu-Da Shen; Cha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

This study investigated the effects of dual endothelin (ET) receptor blockade in rat models of liver ischemia and reperfusion injury (IRI). Three models of IRI were used: (1) in vivo total hepatic warm ischemia with portal shunting for 60 minutes with control (saline) and treatment groups (15 mg/kg